Related Experiment Video
Updated: Sep 17, 2025

Author Spotlight: Exploring Cytoskeletal Dynamics to Unveil Novel Antibiotics Through Innovative Cell-Based Assays
Published on: April 26, 2024
Compounds from Cyclocarya paliurus leaves inhibit binary division of methicillin-resistant Staphylococcus aureus by
Wenlong Chen1, Shuixian Zhang1, Chunxu Huang1
1Center for Infectious Disease and Vaccine Research, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, China.
Abstract:
The escalating threat of methicillin-resistant Staphylococcus aureus (MRSA) necessitates novel therapeutic strategies. Our previous work suggested that an extract from Cyclocarya paliurus leaves (ECPL) inhibits MRSA by targeting the cell division protein FtsZ. Here, guided by anti-MRSA activity, we isolated three compounds from ECPL: asiatic acid (AA), maslinic acid (MA), and ursolic acid (UA). They exhibited antibacterial activity against MRSA and induced cell elongation, indicative of division arrest. Time-kill assays showed AA and MA are bactericides, while UA is bacteriostatic. Mechanistically, these compounds disrupt cell division by differentially affecting FtsZ dynamics: AA promotes polymerization, whereas MA and UA inhibit it. SPR analysis showed direct FtsZ binding to AA (Kd = 2.4 μM), MA (Kd = 9.8 μM), and UA (Kd = 0.7 μM). Molecular docking predicted a shared FtsZ binding pocket but revealed that AA adopts a distinct conformation driven by unique interactions, including a hydrogen bond with Arg191-an interaction not observed for MA or UA, which instead form hydrogen bonds with Thr265 and Thr309. Despite these divergent effects on polymerization and distinct binding modes, all compounds ultimately disrupted Z-ring assembly and septum formation. In a murine skin infection model, AA, selected for its bactericidal activity and unique FtsZ modulation mechanism, significantly reduced bacterial burden and accelerated wound healing. Collectively, our findings validate these compounds as direct FtsZ-targeting agents and establish AA as a promising anti-MRSA lead compound with a novel mechanism disrupting the bacterial divisome.
Insights
Novel compounds from Cyclocarya paliurus leaves target methicillin-resistant Staphylococcus aureus (MRSA) by disrupting cell division protein FtsZ. Asiatic acid shows promise as a bactericidal anti-MRSA lead compound.
Area of Science:
- Microbiology
- Pharmacology
- Medicinal Chemistry
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant public health threat, demanding new therapeutic strategies.
- Previous research indicated that an extract from Cyclocarya paliurus leaves (ECPL) inhibits MRSA by targeting the FtsZ cell division protein.
Purpose of the Study:
- To isolate and characterize compounds from ECPL with anti-MRSA activity.
- To elucidate the mechanism of action of these compounds on MRSA cell division.
- To evaluate the therapeutic potential of the most promising compound in a preclinical model.
Main Methods:
- Isolation of compounds from ECPL using bioactivity-guided fractionation.
- Antibacterial activity assays, time-kill kinetics, and cell elongation measurements.
- Surface Plasmon Resonance (SPR) analysis and molecular docking to study FtsZ interactions.
- In vivo efficacy study using a murine skin infection model.
Main Results:
- Three compounds, asiatic acid (AA), maslinic acid (MA), and ursolic acid (UA), were isolated and showed antibacterial activity against MRSA.
- AA and MA demonstrated bactericidal effects, while UA was bacteriostatic, all inducing cell elongation.
- Compounds differentially modulated FtsZ dynamics: AA promoted polymerization, while MA and UA inhibited it, with direct binding to FtsZ.
- AA exhibited a distinct binding mode to FtsZ compared to MA and UA.
- In vivo, AA significantly reduced bacterial burden and accelerated wound healing in a murine skin infection model.
Conclusions:
- Asiatic acid, maslinic acid, and ursolic acid are direct FtsZ-targeting agents against MRSA.
- Asiatic acid, with its unique FtsZ modulation and bactericidal activity, represents a promising lead compound for developing new anti-MRSA therapies.
- Targeting the bacterial divisome offers a viable strategy for combating MRSA infections.
More Related Videos
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Binary Fission
Combined Effects of Drugs: Synergism
Such synergistic combinations...

